INTVITY LIMITED
Company number 13253797 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
INTVITY LIMITED - Analysis Report
Company Number: 13253797
Analysis Date: 2025-07-29 15:06 UTC
Financial Health Assessment for INTVITY LIMITED (as of 31 March 2024)
1. Financial Health Score: D
Explanation:
INTVITY LIMITED shows significant financial distress, indicated by negative net assets and worsening working capital. The company’s financial position has deteriorated from a marginal deficit last year to a more pronounced negative net worth. This grade reflects a company struggling to maintain financial stability, requiring urgent attention to restore health.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £208 | Very low fixed asset base, indicating minimal long-term investments or infrastructure. |
| Current Assets | £37 | Extremely low liquid assets, limiting ability to meet short-term obligations. |
| Current Liabilities | £768 | High short-term liabilities creating liquidity pressure. |
| Net Current Assets (Working Capital) | -£731 | Negative working capital, a critical symptom of cash flow distress and inability to cover debts. |
| Net Assets (Shareholders’ Funds) | -£523 | Negative equity signals insolvency risk; company owes more than it owns. |
| Share Capital | £1 | Minimal initial capital, insufficient buffer against losses. |
| Employees | 0 | No employees, suggesting either inactivity or reliance on contractors/freelancers. |
3. Diagnosis
INTVITY LIMITED is showing clear signs of financial distress, akin to a patient with a failing vital organ system. The company’s working capital is severely negative, meaning its short-term liabilities significantly exceed its current assets, a strong symptom of liquidity problems. This suggests the company may face difficulty paying suppliers or other creditors on time, risking further financial complications.
The plunge in net assets from -£13 (2023) to -£523 (2024) indicates accumulated losses are eroding equity, much like chronic illness weakening overall health. The minimal fixed assets and share capital provide virtually no cushion to absorb shocks or invest in growth.
No employees are reported, which could imply the business model relies on outsourced services or is in early-stage development, but also means reduced operational capacity and risk of limited revenue generation.
The company operates in IT services and software development, sectors that require investment in innovation and talent—areas that appear financially constrained here.
4. Recommendations
Immediate Actions:
- Cash Flow Management: Urgently improve liquidity by negotiating extended payment terms with creditors and accelerating receivables collection. Consider short-term financing options (e.g., overdraft, invoice financing) to ease cash crunch.
- Cost Control: Minimise operational expenses, especially non-essential costs, to halt further erosion of working capital.
- Capital Injection: Seek fresh equity investment or shareholder loans to restore positive net assets, providing a financial "transfusion" to stabilize the balance sheet.
Medium-Term Strategies:
- Revenue Growth: Focus on securing contracts or sales to generate sustainable cash inflows. The company’s niche in software and IT services offers potential if it can leverage innovation.
- Asset Optimization: Evaluate fixed asset usage and consider divestment of non-essential assets to generate cash.
- Financial Planning: Implement rigorous budgeting and financial monitoring to detect early "symptoms" of distress and avoid future liquidity crises.
Governance and Compliance:
- Continue timely filing and compliance, as currently maintained, to avoid penalties and maintain stakeholder trust.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.